These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8698442)

  • 1. Preglomerular sudanophilia in L-NAME hypertensive rats: involvement of endothelin.
    Bouriquet N; Dupont M; Herizi A; Mimran A; Casellas D
    Hypertension; 1996 Mar; 27(3 Pt 1):382-91. PubMed ID: 8698442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and preglomerular vascular lesions in lyon spontaneously hypertensive rats.
    Casellas D; Bouriquet N; Artuso A
    Acta Physiol Scand; 2000 Jan; 168(1):133-8. PubMed ID: 10691791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candesartan and progression of preglomerular lesions in N(G)-nitro-L-arginine methyl ester hypertensive rats.
    Casellas D; Benahmed S; Artuso A; Jover B
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S230-3. PubMed ID: 9892169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New method for imaging innervation of the renal preglomerular vasculature. Alterations in hypertensive rats.
    Casellas D; Bouriquet N; Artuso A; Walcott B; Moore LC
    Microcirculation; 2000 Dec; 7(6 Pt 1):429-37. PubMed ID: 11142340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bosentan prevents preglomerular alterations during angiotensin II hypertension.
    Casellas D; Bouriquet N; Herizi A
    Hypertension; 1997 Dec; 30(6):1613-20. PubMed ID: 9403591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
    Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic L-NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels.
    Bouriquet N; Casellas D
    Am J Physiol; 1995 Aug; 269(2 Pt 2):F190-7. PubMed ID: 7653592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide modulates vascular tone in preglomerular arterioles.
    Imig JD; Roman RJ
    Hypertension; 1992 Jun; 19(6 Pt 2):770-4. PubMed ID: 1592479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats.
    Tharaux PL; Chatziantoniou C; Casellas D; Fouassier L; Ardaillou R; Dussaule JC
    Circulation; 1999 Apr; 99(16):2185-91. PubMed ID: 10217661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin and endothelium-derived relaxing factor control of basal renovascular tone in hydronephrotic rat kidneys.
    Gulbins E; Hoffend J; Zou AP; Dietrich MS; Schlottmann K; Cavarape A; Steinhausen M
    J Physiol; 1993 Sep; 469():571-82. PubMed ID: 8271216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of renal vascular fibrosis by endothelin receptor antagonism.
    Boffa JJ; Tharaux PL; Dussaule JC; Chatziantoniou C
    Hypertension; 2001 Feb; 37(2 Pt 2):490-6. PubMed ID: 11230324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension.
    Fernández-Rivas A; García-Estañ J; Vargas F
    J Hypertens; 1995 Jan; 13(1):123-8. PubMed ID: 7759842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
    Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
    Eur J Pharmacol; 1995 Jul; 280(3):311-6. PubMed ID: 8566099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
    Chatziantoniou C; Boffa JJ; Ardaillou R; Dussaule JC
    J Clin Invest; 1998 Jun; 101(12):2780-9. PubMed ID: 9637712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats.
    Richard V; Hogie M; Clozel M; Löffler BM; Thuillez C
    Circulation; 1995 Feb; 91(3):771-5. PubMed ID: 7828305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension.
    Moreau P; Takase H; Küng CF; Shaw S; Lüscher TF
    Hypertension; 1997 Mar; 29(3):763-9. PubMed ID: 9052893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endothelin ET(A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment.
    Pollock DM; Polakowski JS; Opgenorth TJ; Pollock JS
    Eur J Pharmacol; 1998 Apr; 346(1):43-50. PubMed ID: 9617750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H; Ono Y; Frohlich ED
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade.
    Yamada SS; Sassaki AL; Fujihara CK; Malheiros DM; De Nucci G; Zatz R
    Hypertension; 1996 May; 27(5):1165-72. PubMed ID: 8621212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.